What is the recommended dosing for Sari to augment with Wellbutrin (bupropion)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing for Trazodone (Sari) Augmentation with Bupropion (Wellbutrin)

For trazodone augmentation with bupropion, start with trazodone 50-100 mg at bedtime and bupropion SR 100-150 mg in the morning, with potential titration of bupropion to 100-150 mg twice daily (maximum 300 mg/day) based on response and tolerability. 1

Dosing Guidelines

Bupropion (Wellbutrin) Dosing

  • SR (Sustained Release) formulation:

    • Starting dose: 100-150 mg once daily in the morning 1
    • Maintenance dose: 100-150 mg twice daily 1
    • Maximum daily dose: 300 mg per day (divided doses) 1
  • XL (Extended Release) formulation:

    • Starting dose: 150 mg once daily in the morning 1
    • Maintenance dose: 150-300 mg once daily 1
    • Maximum daily dose: 450 mg per day 1

Trazodone (Sari) Dosing for Augmentation

  • Starting dose: 50-100 mg at bedtime
  • Titration: Increase by 50 mg increments every 3-7 days as needed
  • Typical augmentation dose range: 50-200 mg at bedtime

Clinical Considerations

Benefits of This Combination

  • Complementary mechanisms of action:
    • Bupropion: Dopamine/norepinephrine reuptake inhibitor 2
    • Trazodone: Serotonin antagonist and reuptake inhibitor
  • Trazodone can help manage insomnia that may occur with bupropion 3
  • Bupropion's activating properties balance trazodone's sedating effects 3

Timing of Administration

  • Bupropion SR: Morning dose and second dose (if applicable) before 3 PM to minimize insomnia 3
  • Trazodone: Administer at bedtime to leverage sedating properties

Monitoring Parameters

  • Assess for improvement in target symptoms after 4-6 weeks 1
  • Monitor for side effects:
    • Insomnia, agitation, dry mouth (bupropion)
    • Sedation, orthostatic hypotension (trazodone)
    • Seizure risk (both medications, though low incidence)

Contraindications and Precautions

  • Absolute contraindications:

    • Seizure disorders
    • Current or prior diagnosis of bulimia or anorexia nervosa
    • Concurrent use of MAOIs 3
    • Abrupt discontinuation of alcohol or sedatives
  • Use with caution in:

    • Patients with history of cardiovascular disease
    • Renal or hepatic impairment (may require dose adjustment)
    • Elderly patients (start with lower doses)

Special Populations

Elderly

  • Start with lower doses of both medications
  • Bupropion SR: Start with 100 mg once daily
  • Trazodone: Start with 25-50 mg at bedtime

Renal/Hepatic Impairment

  • Bupropion: Reduce dose in moderate to severe impairment
  • Trazodone: Start at lower doses and titrate slowly

Discontinuation Criteria

  • If inadequate response after 6-8 weeks at optimal doses
  • If intolerable side effects occur
  • For bupropion SR/XL: Consider discontinuation if <5% improvement in target symptoms after 12 weeks 1

Potential Drug Interactions

  • Monitor for increased risk of seizures when combining these medications
  • Avoid alcohol consumption which may increase CNS depression with trazodone and seizure risk with bupropion
  • Use caution with other medications that lower seizure threshold

This combination leverages the activating properties of bupropion with the sedating effects of trazodone, potentially addressing both daytime energy/motivation and nighttime sleep issues while minimizing the sexual side effects often seen with other antidepressant combinations.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Augmentation Strategies for Partial Response to Antidepressants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.